Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2011

01-01-2011 | Original Article

The Role of Oral Hygiene in Inflammatory Bowel Disease

Authors: Shashideep Singhal, Delia Dian, Ali Keshavarzian, Louis Fogg, Jeremy Z. Fields, Ashkan Farhadi

Published in: Digestive Diseases and Sciences | Issue 1/2011

Login to get access

Abstract

Background

The ‘hygiene hypothesis’ suggests that a reduction in the microbial exposure due to improved health measures has contributed to an immunological imbalance in the intestine and increased the incidence of autoimmune diseases such as inflammatory bowel diseases (IBD). Accordingly, we investigated associations between oral hygiene practices and IBD.

Methods

We developed and administered a multiple choice questionnaire to evaluate oral hygiene and dental care practices of 137 subjects (83 with IBD and 54 healthy controls).

Results

Of the 83 IBD cases, 31% had ulcerative colitis and 69% had Crohn’s disease. For subjects with IBD, the frequency of brushing at disease onset was significantly higher than in controls (P = 0.005). Also, the frequency of use of dental floss and breath freshener at disease onset was significantly higher in IBD patients (P = 0.005 and <0.001, respectively). Also, patients with IBD more frequently visited their dentist at disease onset (P < 0.001) and continued to visit their dentist more often (P < 0.001). IBD cases had a higher frequency of dental complications such as tooth caries (P = 0.007), oral ulcers (P = 0.04) and dry mouth (P = 0.001).

Conclusions

These findings suggest that oral hygiene practices may cause alterations in the flora of the oral mucosa, which causes imbalance in the gut microbiome (dysbiosis), and thereby contributes to the pathogenesis of IBD. Conversely, the increased frequency of dental problems in IBD patients might be due, at least in part, to alterations in oral flora or to their disease.
Literature
1.
go back to reference Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 2004;12(12):562–568.CrossRefPubMed Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 2004;12(12):562–568.CrossRefPubMed
2.
go back to reference Elson CO, Cong Y, McCracken VJ, et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev. 2005;206:260–276.CrossRefPubMed Elson CO, Cong Y, McCracken VJ, et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev. 2005;206:260–276.CrossRefPubMed
3.
go back to reference Seksik P, Sokol H, Lepage P, et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24(Suppl 3):11–18.CrossRefPubMed Seksik P, Sokol H, Lepage P, et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24(Suppl 3):11–18.CrossRefPubMed
4.
go back to reference Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53(1):1–4.CrossRefPubMed Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53(1):1–4.CrossRefPubMed
5.
go back to reference Rochet V, Rigottier-Gois L, Sutren M, et al. Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br J Nutr. 2006;95(2):421–429.CrossRefPubMed Rochet V, Rigottier-Gois L, Sutren M, et al. Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br J Nutr. 2006;95(2):421–429.CrossRefPubMed
6.
go back to reference Sullivan SN. Hypothesis revisited: toothpaste and the cause of Crohn’s disease. Lancet. 1990;336(8723):1096–1097.CrossRefPubMed Sullivan SN. Hypothesis revisited: toothpaste and the cause of Crohn’s disease. Lancet. 1990;336(8723):1096–1097.CrossRefPubMed
7.
go back to reference Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005;39(4 Suppl 2):S59–S65.CrossRefPubMed Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005;39(4 Suppl 2):S59–S65.CrossRefPubMed
9.
go back to reference Maukonen J, Mättö J, Suihko ML, et al. Intra-individual diversity and similarity of salivary and faecal microbiota. J Med Microbiol. 2008;57(Pt 12):1560–1568.CrossRefPubMed Maukonen J, Mättö J, Suihko ML, et al. Intra-individual diversity and similarity of salivary and faecal microbiota. J Med Microbiol. 2008;57(Pt 12):1560–1568.CrossRefPubMed
10.
go back to reference Kalliomäki M, Salminen S, Isolauri E. Positive interactions with the microbiota: probiotics. Adv Exp Med Biol. 2008;635:57–66.CrossRefPubMed Kalliomäki M, Salminen S, Isolauri E. Positive interactions with the microbiota: probiotics. Adv Exp Med Biol. 2008;635:57–66.CrossRefPubMed
11.
go back to reference Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–1189. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–1189.
12.
go back to reference Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105(43):16731–16736.CrossRefPubMed Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105(43):16731–16736.CrossRefPubMed
13.
go back to reference Attin T, Hornecker E. Tooth brushing and oral health: how frequently and when should tooth brushing be performed? Oral Health Prev Dent. 2005;3(3):135–140.PubMed Attin T, Hornecker E. Tooth brushing and oral health: how frequently and when should tooth brushing be performed? Oral Health Prev Dent. 2005;3(3):135–140.PubMed
14.
go back to reference Katz J, Shenkman A, Stavropoulos F, et al. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 2003;9(1):34–40.CrossRefPubMed Katz J, Shenkman A, Stavropoulos F, et al. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 2003;9(1):34–40.CrossRefPubMed
15.
go back to reference Snyder MB, Cawson RA. Oral changes in Crohn’s disease. J Oral Surg. 1976;34(7):594–599.PubMed Snyder MB, Cawson RA. Oral changes in Crohn’s disease. J Oral Surg. 1976;34(7):594–599.PubMed
16.
go back to reference Harty S, Fleming P, Rowland M, et al. A prospective study of the oral manifestations of Crohn’s disease. Clin Gastroenterol Hepatol. 2005;3(9):886–891.CrossRefPubMed Harty S, Fleming P, Rowland M, et al. A prospective study of the oral manifestations of Crohn’s disease. Clin Gastroenterol Hepatol. 2005;3(9):886–891.CrossRefPubMed
17.
go back to reference Grössner-Schreiber B, Fetter T, Hedderich J, et al. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol. 2006;33(7):478–484.CrossRefPubMed Grössner-Schreiber B, Fetter T, Hedderich J, et al. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol. 2006;33(7):478–484.CrossRefPubMed
18.
go back to reference Brito F, de Barros FC, Zaltman C, et al. Prevalence of periodontitis and DMFT index in patients with Crohn’s disease and ulcerative colitis. J Clin Periodontol. 2008;35(6):555–560.CrossRefPubMed Brito F, de Barros FC, Zaltman C, et al. Prevalence of periodontitis and DMFT index in patients with Crohn’s disease and ulcerative colitis. J Clin Periodontol. 2008;35(6):555–560.CrossRefPubMed
19.
go back to reference Van Dyke TE, Dowell VR Jr, Offenbacher S, et al. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun. 1986;53(3):671–677.PubMed Van Dyke TE, Dowell VR Jr, Offenbacher S, et al. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun. 1986;53(3):671–677.PubMed
20.
go back to reference Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7(1):47–51.PubMed Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7(1):47–51.PubMed
21.
go back to reference Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol. 2008;14(2):165–173.CrossRefPubMed Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol. 2008;14(2):165–173.CrossRefPubMed
Metadata
Title
The Role of Oral Hygiene in Inflammatory Bowel Disease
Authors
Shashideep Singhal
Delia Dian
Ali Keshavarzian
Louis Fogg
Jeremy Z. Fields
Ashkan Farhadi
Publication date
01-01-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1263-9

Other articles of this Issue 1/2011

Digestive Diseases and Sciences 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.